Canada markets closed

Genesis Healthcare, Inc. (GENN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00130.0000 (0.00%)
At close: 02:22PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.04M
Enterprise Value 3.60B
Trailing P/E 1.29
Forward P/E 0.01
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.00
Price/Book (mrq)N/A
Enterprise Value/Revenue 0.92
Enterprise Value/EBITDA 26.41

Trading Information

Stock Price History

Beta (5Y Monthly) -0.48
52-Week Change 3-89.17%
S&P500 52-Week Change 322.38%
52 Week High 30.3756
52 Week Low 30.0001
50-Day Moving Average 30.0013
200-Day Moving Average 30.0016

Share Statistics

Avg Vol (3 month) 314.82k
Avg Vol (10 day) 313.44k
Shares Outstanding 5111.73M
Implied Shares Outstanding 61.57B
Float 8111.79M
% Held by Insiders 10.00%
% Held by Institutions 10.03%
Shares Short (Mar 15, 2021) 42.3M
Short Ratio (Mar 15, 2021) 40.21
Short % of Float (Mar 15, 2021) 42.85%
Short % of Shares Outstanding (Mar 15, 2021) 41.38%
Shares Short (prior month Feb 12, 2021) 41.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2020
Most Recent Quarter (mrq)Dec 31, 2020

Profitability

Profit Margin -1.51%
Operating Margin (ttm)-7.36%

Management Effectiveness

Return on Assets (ttm)-3.86%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)3.91B
Revenue Per Share (ttm)34.92
Quarterly Revenue Growth (yoy)-19.10%
Gross Profit (ttm)N/A
EBITDA -161.94M
Net Income Avi to Common (ttm)-58.96M
Diluted EPS (ttm)-0.0600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)212.07M
Total Cash Per Share (mrq)1.89
Total Debt (mrq)3.81B
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.23
Book Value Per Share (mrq)-7.35

Cash Flow Statement

Operating Cash Flow (ttm)315.73M
Levered Free Cash Flow (ttm)-143.07M